Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Blood Cancer Journal
|
October 24, 2025
Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance
Elena Alejo, Verónica González-Calle, Patricia Blázquez, et al.
Hemasphere
|
November 15, 2019
Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma
Víctor Higuero Saavedra, Verónica González-Calle, Eduardo Sobejano, et al.
Blood Cancer Journal
|
March 20, 2023
Multiple myeloma with t(11;14): impact of novel agents on outcome
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, et al.
Medicine
|
May 11, 2017
Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report
Ana María Cubo, Zandra Mileny Soto, Miguel Ángel Cruz, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
European Journal of Haematology
|
April 24, 2024
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
Hans C Lee, Karthik Ramasamy, Margaret Macro, et al.
Haematologica
|
November 9, 2014
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
Bruno Paiva, Mauricio Chandia, Noemi Puig, et al.
Blood Advances
|
May 8, 2024
A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma
Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo, et al.
Molecular Oncology
|
July 17, 2025
Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation
Ignacio J Cardona-Benavides, Sara Cristobal-Vargas, Cristina De Ramón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 9, 2018
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
Sarah A Holstein, J Christine Ye, Alan Howard, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Blood Cancer Journal
|
October 24, 2025
Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance
Elena Alejo, Verónica González-Calle, Patricia Blázquez, et al.
Hemasphere
|
November 15, 2019
Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma
Víctor Higuero Saavedra, Verónica González-Calle, Eduardo Sobejano, et al.
Blood Cancer Journal
|
March 20, 2023
Multiple myeloma with t(11;14): impact of novel agents on outcome
Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, et al.
Medicine
|
May 11, 2017
Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report
Ana María Cubo, Zandra Mileny Soto, Miguel Ángel Cruz, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
European Journal of Haematology
|
April 24, 2024
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
Hans C Lee, Karthik Ramasamy, Margaret Macro, et al.
Haematologica
|
November 9, 2014
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
Bruno Paiva, Mauricio Chandia, Noemi Puig, et al.
Blood Advances
|
May 8, 2024
A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma
Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo, et al.
Molecular Oncology
|
July 17, 2025
Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation
Ignacio J Cardona-Benavides, Sara Cristobal-Vargas, Cristina De Ramón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 9, 2018
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
Sarah A Holstein, J Christine Ye, Alan Howard, et al.
Page
of 9